SCHEMBL23312134

SCHEMBL23312134

CC(C)N1CCN(C(=O)C2CO2)CC1C

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.32
HRH3 Q9Y5N1 5/20 0.32
EGLN1 Q9GZT9 3/20 0.31
RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23312135 0.81 HRH3 (0.32) HRH3EGLN1
SCHEMBL21867124 0.78 HRH3 (0.36) SLC6A9HRH3EGLN1
SCHEMBL25704492 0.78 PIK3CD (0.40) SLC6A9HRH3
SCHEMBL16257031 0.77 GPX4 (0.38) SLC6A9EGLN1
SCHEMBL23312170 0.75 MAPT (0.43)
SCHEMBL23312132 0.75 SLC6A9 (0.31) SLC6A9HRH3EGLN1
SCHEMBL23312164 0.74 HRH3 (0.45) HRH3RECQL
SCHEMBL3857094 0.74 CHRNB2 (0.45) HRH3EGLN1
SCHEMBL3857098 0.74 CHRNB2 (0.45) HRH3EGLN1
SCHEMBL23876808 0.73 MEN1 (0.36) SLC6A9HRH3EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021081212-A1 PYRIDOPYRIMIDINE DERIVATIVES USEFUL AS KRAS G12C AND KRAS G12D INHIBITORS IN THE TREATMENT OF CANCER AMGEN INC. (US) 2021-04-29 WO disclosed